Radiopharmaceuticals for Persistent or Recurrent Uterine Cervix Cancer

Frontiers in Oncology - Switzerland
doi 10.3389/fonc.2019.00560
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Frontiers Media SA

Related search

Surgery for Recurrent Uterine Cancer

International Journal of Gynecological Cancer
GynecologyOncologyObstetrics
2017English

Phase II Trial of Nab-Paclitaxel in the Treatment of Recurrent or Persistent Advanced Cervix Cancer: A Gynecologic Oncology Group Study

Gynecologic Oncology
GynecologyOncologyObstetrics
2012English

Cigarette Smoking and Cancer of the Uterine Cervix

British Journal of Cancer
Cancer ResearchOncology
1985English

Intravitreal Melphalan for Persistent or Recurrent Retinoblastoma Vitreous Seeds

JAMA Ophthalmology
Ophthalmology
2014English

Phase II Study of Bevacizumab and Pemetrexed for Recurrent or Persistent Epithelial Ovarian, Fallopian Tube or Primary Peritoneal Cancer

Gynecologic Oncology
GynecologyOncologyObstetrics
2013English

A Systematic Review of Outcomes After Salvage Abdominoperineal Resection for Persistent or Recurrent Anal Squamous Cell Cancer

Colorectal Disease
Gastroenterology
2019English

Photodynamic Therapy in the Therapy for Recurrent/Persistent Nasopharyngeal Cancer

Head & Neck Oncology
2009English

Modulation of Novel DNA Adducts During Human Uterine Cervix Cancer Progression

International Journal of Oncology
Cancer ResearchOncology
2006English

Hypercalciuria as a Cause of Persistent or Recurrent Haematuria.

Archives of Disease in Childhood
Child HealthPediatricsPerinatology
1988English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy